Clinical trials
Completed Hallucinations trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
70 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 8 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 3 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 70 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 5 |
| ACADIA Pharmaceuticals Inc. | 3 |
| University of North Carolina, Chapel Hill | 3 |
| Charite University, Berlin, Germany | 2 |
| Ciusss de L'Est de l'Île de Montréal | 2 |
| Hôpital le Vinatier | 2 |
| National Institute of Mental Health (NIMH) | 2 |
| New York State Psychiatric Institute | 2 |
| Novartis Pharmaceuticals | 2 |
| Seoul National University Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hallucinations | 70 |
| Schizophrenia | 45 |
| Psychotic Disorders | 28 |
| Dementia | 5 |
| Parkinson Disease | 5 |
| Schizophrenia, Treatment-Resistant | 5 |
| Alzheimer Disease | 4 |
| Mental Disorders | 4 |
| Paranoid Disorders | 3 |
| Charles Bonnet Syndrome | 2 |
Trials
Showing 51 to 70 of 70. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.